Amneal Pharma: JPMorgan raises target price to $25 from $24
AMRX•JPMorgan raised its target price for Amneal Pharma to $25 from $24.
Related News
RBC raises Pfizer target price to $28 from $25
PFE•
Leerink Partners cuts Ideaya Biosciences target price to $30 from $31
IDYA•
Amdocs management commentary on Q4 FY2026: Restructuring charge weighs on GAAP EPS
DOX•
Ultragenyx Pharmaceutical: Canaccord Genuity cuts target price to $34 from $39
RARE•
AtriCure target price raised to $67 from $55
ATRC•